ADDvise receives frame agreement from SLL at an order value of 20 + 20 MSEK

IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement for laparoscopy products from the County Council of Stockholm. The estimated value of the agreement for IM-Medico is 10 MSEK per annum. The agreement runs for two years with a two-year prolongation option.

IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement from the County Council of Stockholm for laparoscopy products. These products are used in laparoscopy procedures with internal stapling for invasive surgery. IM-Medico has been chosen as the preferred supplier in competition with vendors such as Johnsson & Johnsson and Medtronic.

-       Rikard Akhtarzand comments the business; “Our extensive investment in the surgery segment is now paying off. To be chosen as the preferred supplier in competition with Johnsson & Johnsson and Medtronic is a major achievement for us”.

The agreement has a standstill period until January 19 2017 and starts running on June 1 2017.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se 

Important information: 

This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 10, 2017 at 08:45 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.